ClinConnect ClinConnect Logo
Search / Trial NCT00247949

Accuracy of Non-invasive Continuous CO2-Monitoring

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Nov 1, 2005

Trial Information

Current as of May 22, 2025

Terminated

Keywords

Carbon Dioxide Monitoring Major Surgery Repeated Blood Gas Testing Carbon Dioxide Monitoring

ClinConnect Summary

Measurement of SO2 is used in nearly every patient receiving anesthesia or sedation, whereas monitoring of pCO2 is important in patients during and shortly after major surgery and in critically ill patients. But measurement of pCO2 requires arterial blood sampling and laboratory testing. Non-invasive monitors for continuous assessment of arterial pCO2 have been developed but their accuracy and feasibility were insufficient to make them useful in the clinical setting. Recently, a new digital system for continuous and non-invasive monitoring of arterial pCO2 and SO2 has been introduced (SenTe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients older than 18 years with clinical indication of repeated arterial blood gas analyses
  • Exclusion Criteria:
  • No informed consent

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, Ch, Switzerland

Patients applied

0 patients applied

Trial Officials

Daniel Bolliger, Dr.

Principal Investigator

Department of Anaesthesia University Hospital Basel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials